The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kardos P, Hagedorn-Peinz I
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017-12-01
Serie:International Journal of COPD
Soggetti:
COPD
dual-bronchodilators
FEV1
indacaterol/glycopyrronium
treatment preference
treatment satisfaction
Accesso online:https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi